Reference region extraction by clustering for the pharmacokinetic analysis of dynamic contrast-enhanced MRI in prostate cancer.
暂无分享,去创建一个
Yasuhiko Tachibana | Tokuhiko Omatsu | Riwa Kishimoto | Tatsuya Higashi | Takayuki Obata | Yoko Ikoma | Goro Kasuya | Hirokazu Makishima | Hiroshi Tsuji | T. Obata | T. Higashi | Y. Tachibana | Y. Ikoma | H. Tsuji | T. Omatsu | R. Kishimoto | G. Kasuya | H. Makishima
[1] J Kurhanewicz,et al. Dynamic contrast‐enhanced MRI in normal and abnormal prostate tissues as defined by biopsy, MRI, and 3D MRSI , 2005, Magnetic resonance in medicine.
[2] D. Dearnaley,et al. Dynamic contrast-enhanced MRI for prostate cancer localization. , 2009, The British journal of radiology.
[3] Ivan Yeung,et al. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast–enhanced MRI and CT , 2010, Magnetic resonance in medicine.
[4] A. Jackson,et al. Experimentally‐derived functional form for a population‐averaged high‐temporal‐resolution arterial input function for dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[5] A. Oto,et al. Arterial input functions (AIFs) measured directly from arteries with low and standard doses of contrast agent, and AIFs derived from reference tissues. , 2016, Magnetic resonance imaging.
[6] Richard Frayne,et al. The impact of partial‐volume effects in dynamic susceptibility contrast magnetic resonance perfusion imaging , 2005, Journal of magnetic resonance imaging : JMRI.
[7] Geoff J M Parker,et al. The effect of blood inflow and B1‐field inhomogeneity on measurement of the arterial input function in axial 3D spoiled gradient echo dynamic contrast‐enhanced MRI , 2011, Magnetic resonance in medicine.
[8] Steven P Sourbron,et al. Classic models for dynamic contrast‐enhanced MRI , 2013, NMR in biomedicine.
[9] Gregory S Karczmar,et al. Multiple reference tissue method for contrast agent arterial input function estimation , 2007, Magnetic resonance in medicine.
[10] Guang-Zhong Yang,et al. Bayesian Methods for Pharmacokinetic Models in Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2006, IEEE Transactions on Medical Imaging.
[11] Evis Sala,et al. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. , 2007, The Lancet. Oncology.
[12] Henkjan J Huisman,et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. , 2003, Radiology.
[13] David Atkinson,et al. Bayesian estimation of pharmacokinetic parameters for DCE-MRI with a robust treatment of enhancement onset time. , 2007, Physics in medicine and biology.
[14] Joseph S Koopmeiners,et al. Detection of Prostate Cancer: Quantitative Multiparametric MR Imaging Models Developed Using Registered Correlative Histopathology. , 2016, Radiology.
[15] J. Gore,et al. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. , 2005, Magnetic resonance imaging.
[16] Alberto Righetti,et al. Inflow effect in first‐pass cardiac and renal MRI , 2003, Journal of magnetic resonance imaging : JMRI.
[17] A. Evans,et al. Prostate cancer detection with multi‐parametric MRI: Logistic regression analysis of quantitative T2, diffusion‐weighted imaging, and dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[18] Yuichi Kimura,et al. Improved Signal-to-Noise Ratio in Parametric Images by Cluster Analysis , 1999, NeuroImage.
[19] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[20] Dow-Mu Koh,et al. Assessment of the effect of haematocrit‐dependent arterial input functions on the accuracy of pharmacokinetic parameters in dynamic contrast‐enhanced MRI , 2011, NMR in biomedicine.
[21] Vincent J. Cunningham,et al. Parametric Imaging of Ligand-Receptor Interactions Using a Reference Tissue Model and Cluster Analysis , 1998 .
[22] D J Collins,et al. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis , 2006, Physics in medicine and biology.
[23] F. Turkheimer,et al. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[24] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[25] E. Rostrup,et al. Measurement of the arterial concentration of Gd‐DTPA using MRI: A step toward quantitative perfusion imaging , 1996, Magnetic resonance in medicine.
[26] David Atkinson,et al. A comparison of Bayesian and non-linear regression methods for robust estimation of pharmacokinetics in DCE-MRI and how it affects cancer diagnosis , 2017, Comput. Medical Imaging Graph..
[27] Hai-Ling Margaret Cheng,et al. T1 measurement of flowing blood and arterial input function determination for quantitative 3D T1‐weighted DCE‐MRI , 2007, Journal of magnetic resonance imaging : JMRI.
[28] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[29] David Atkinson,et al. Computationally efficient vascular input function models for quantitative kinetic modelling using DCE-MRI , 2008, Physics in medicine and biology.
[30] K Wells,et al. Partial volume effects in dynamic contrast magnetic resonance renal studies. , 2010, European journal of radiology.
[31] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[32] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[33] G S Karczmar,et al. A new method for imaging perfusion and contrast extraction fraction: Input functions derived from reference tissues , 1998, Journal of magnetic resonance imaging : JMRI.
[34] Gregory S Karczmar,et al. Estimating the arterial input function using two reference tissues in dynamic contrast‐enhanced MRI studies: Fundamental concepts and simulations , 2004, Magnetic resonance in medicine.
[35] Steven P Sourbron,et al. On the scope and interpretation of the Tofts models for DCE‐MRI , 2011, Magnetic resonance in medicine.
[36] R. Wirestam,et al. Effects of inflow and radiofrequency spoiling on the arterial input function in dynamic contrast‐enhanced MRI: A combined phantom and simulation study , 2011, Magnetic resonance in medicine.
[37] Evis Sala,et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. , 2009, International journal of radiation oncology, biology, physics.
[38] L. R. Jensen,et al. Peripheral Zone Prostate Cancer Localization by Multiparametric Magnetic Resonance at 3 T: Unbiased Cancer Identification by Matching to Histopathology , 2012, Investigative radiology.
[39] A R Padhani,et al. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. , 2001, Clinical radiology.
[40] Stuart A. Taylor,et al. Zone-specific logistic regression models improve classification of prostate cancer on multi-parametric MRI , 2015, European Radiology.
[41] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.